Compound ID | 2003
Synonym(s): Dynabac | LY 237216
Class: Small molecule antibacterial agent
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Protein synthesis inhibitor. Binds to the peptidyl transferase component of the bacterial 50S ribosomal subunit, thus inhibiting peptide bond formation |
| Description: | Semisynthetic erythromycin derivative |
| Institute where first reported: | Lilly Research Labs |
| Year first mentioned: | 1987 |
| Highest development stage: | Approved by FDA in 1995 |
| Development status: | Approved |
| Reason dropped: | Discontinued/Withdrawn in US |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/6473883 |
| Guide to Pharmacology: | dirithromycin |
| Citations: |
|